Previously described alterations of the RAS in patients with Cushing’s syndrome include higher levels of angiotensinogen (10), despite lower (10, 11) or unchanged (12, 13) renin levels and an increased sensitivity to angiotensin II (12, 14). This evidence concerns the gene AGT and Cushing syndrome.